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ABSTRACT
Aims/Introduction: Abnormalities in Ca2+ signaling have a key role in hemodynamic 
dysfunction in diabetic heart. The purpose of this study was to explore the effects of streptozotocin A
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(STZ) - induced diabetes on Ca2+ signaling in epicardial (EPI) and endocardial (ENDO) cells of 
the left ventricle, after 5-6 months of STZ injection. Materials and Methods: Whole-cell patch 
clamp was used to measure L-type Ca2+ channel (LTCC) and Na+/Ca2+ exchanger (NCX) currents. 
Fluorescence photometry techniques were used to measure intracellular free Ca2+ concentration 
[Ca2+]i. Results: Although LTCC current was not significantly altered, the amplitude (AMP) of 
Ca2+ transients increased significantly in EPI-STZ and ENDO-STZ compared to controls. Time to 
peak (TPK) LTCC current, TPK Ca2+ transient, time to half (THALF) decay of LTCC current and 
THALF decay of Ca2+ transients were not significantly changed in EPI-STZ and ENDO-STZ 
myocytes compared to controls. NCX current was significantly smaller in EPI-STZ and in ENDO-
STZ compared to controls. Conclusions: STZ-induced diabetes resulted in an increase in AMP of 
Ca2+ transients in EPI and ENDO myocyte that was independent of LTCC current. Such an effect 
can be attributed, at least in part, to the dysfunction of NCX. Additional studies are warranted to 
improve our understanding of the regional impact of diabetes on Ca2+ signaling, which will 
facilitate the discovery of new targeted treatments for diabetic cardiomyopathy.
KEYWORDS: Streptozotocin-induced diabetes; ventricular myocytes; Ca2+ transients; L-type 
Ca2+ channel; Na+/Ca2+ exchanger
INTRODUCTION
Cardiac contractility is controlled by variations in the concentration of intracellular free Ca2+ 
[Ca2+]i. During the process of excitation-contraction coupling (ECC), depolarization of the 
ventricular myocyte causes the opening of measure L-type Ca2+ channel (LTCCs) and the influx 
of small amounts of Ca2+ into the cardiac cell. This influx of Ca2+ stimulates a large release of Ca2+ 
(Ca2+ transient) from the sarcoplasmic reticulum (SR) via the ryanodine receptors (RyR) resulting 
in a transient rise of intracellular [Ca2+] (Ca2+ transient). Ca2+ attaches to troponin C which 
initiates and regulates the process of myocyte contraction. During the process of myocyte 
relaxation Ca2+ is removed from the  cytoplasm through four main pathways: the uptake of Ca2+ 
into the SR through SR Ca2+-ATPase (SERCA pump), efflux of Ca2+ from the cell primarily via 
the Na+/Ca2+ exchanger (NCX), and to a lesser extent the Ca2+-ATPase in the plasma membrane 
(1) and also uptake of Ca2+ by the mitochondria (2, 3).A
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Disturbances in the mechanism(s) of Ca2+ signaling will inevitably have implications for 
cardiac myocyte contraction. Previous studies in left ventricle cells obtained from the STZ-treated 
rat have shown alterations in the Ca2+ transient including prolonged TPK (4, 5), prolonged 
THALF relaxation (6), and unaltered (7) or reduced (8) amplitude of Ca2+ transient. These 
alterations in Ca2+ transient may be attributed variously to diminished SR Ca2+ content, release 
and uptake (9-11), reduced activity of L-type Ca2+ channel (12-14) and NCX (7, 13).
Supporting these findings, earlier studies on STZ-treated rats have variously reported reduced 
cardiac output, fractional shortening and ejection fraction (4, 14, 15). In cardiac cells isolated from 
STZ-treated rat, there was prolonged time course of shortening (6, 16, 17), frequently prolonged 
relaxation (4, 16) and slowed velocity of shortening and re-lengthening (14). Studies have also 
shown either no significant change (6, 12) or reduction (14) in the amplitude of shortening. These 
different results could be partly attributed to duration of diabetes or methodology employed in the 
experiments.
It is well known that the electromechanical characteristics of cardiac cells across the 
ventricular walls are different. This heterogeneity is partly attributed to distinctive expression of 
different ion channels and associated ionic currents which lead to variation in action potential 
waveforms seen in epicardial (EPI), midmyocardial (mid) and endocardial (ENDO) cells (18-20). 
For example, in vivo echocardiographic studies in rat ventricular myocardium have shown that 
layers of the epicardium contract less and slower than the layers of the sub-endocardium (21). It is 
important to highlight that any disruption in the differential distribution of ion channels 
responsible for Ca2+ transport across the walls of the ventricles is expected to be involved in the 
dysfunction of cardiac cells in disease (7, 15, 22, 23). Earlier work in spontaneously hypertensive 
rat has shown transmurally altered time course and amplitude of action potential, variation in Ca2+ 
transients and contraction in sub-EPI and sub-ENDO myocytes during compensated hypertrophy 
(24). Transmural alteration in the activity of NCX, Ca2+ content of the SR and AMP of Ca2+ 
transient have also been shown in an earlier study in spontaneously hypertensive rat (25). 
To date, only a few studies have explored the transmural effect of STZ-induced diabetes on 
Ca2+ signaling in ventricular myocytes (26-28). For this reason, the current work was undertaken 
to investigate the progressive regional effects of diabetes on ventricular myocytes. To the best of 
our knowledge, this is the first study that investigates the effects of STZ-induced diabetes on 
LTCC current simultaneously measured with Ca2+ transients. Previous experiments have generally 
measured LTCC current and Ca2+ transient in separate experiments. The influx of Ca2+ through A
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LTCCs is inextricably linked to the release of Ca2+ from the SR (Ca2+-induced Ca2+ release). 
Therefore, this study has investigated the effects of STZ-induced diabetes on LTCC current 
simultaneously measured with intracellular [Ca2+] and also NCX current in EPI and ENDO 
ventricular myocytes from rats 5-6 months after the induction of diabetes. 
MATERIALS AND METHODS
Experimental Model
Experiments were conducted in STZ-induced diabetic rats (29, 30). A single intraperitoneal 
injection of STZ (60 mg/kg bodyweight) in citrate buffer was used to induced diabetes in young 
adult (220-250 g) male Wistar rats. Age-matched control animals were injected with citrate buffer 
alone. Rats were kept at 12/12 h light/dark cycle. Food and water were supplied ad libitum. Both 
control and experimental groups received standard pelleted rat chow.
Prior to each experiment, body and heart weights, in addition to non-fasting blood glucose 
level (OneTouch Ultra 2, LifeScan) were measured. All experiments were done 5-6 months after 
treatment with STZ in ENDO and EPI myocytes. Ethical approval of the work was received from 
the UAE University (UAEU) Animal Research Ethics Committee (UAE University, A11-15, 
2015). All experiments were performed according to the institution guidelines. 
Isolation of Ventricular Myocytes
Ventricular myocytes were obtained by enzymatic and mechanical dispersal techniques in 
accordance with previously described protocols (24, 27, 28). Animals were euthanized with a 
guillotine. Hearts were isolated, mounted on a Langendorff system for retrograde perfusion and 
perfused at 36-37 ºC with a cell isolation solution (see supporting information) (27). Perfusion 
flow rate was 8 ml/g heart-1.min-1. Upon stabilization of heart contraction, perfusion was switched 
to Ca2+-free cell isolation solution containing EGTA (0.1 mmol/l) for 4 min and then to cell 
isolation solution containing  Ca2+ (0.05 mmol/l ), type 1 collagenase (0.60 mg/ml) and type XIV 
protease (0.075 mg/ml) for 6 min. Upon completion of enzymatic treatment, hearts were detached 
from the Langendorff perfusion system and the left ventricle was further dissected as described in 
earlier studies (27, 28). Thin sections were carefully dissected by fine scissors from the outermost 
layer (EPI) and innermost layer (ENDO) of the left ventricle. The sections were gently minced and 
shaken in an isolation solution containing collagenase and 1% bovine serum albumin. Cells were 
then filtered at 4 min intervals and re-suspended in cell isolation solution that contained 0.75 
mmol/l Ca2+.A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Simultaneous Recording of L-type Ca2+ Current and Ca2+ Transient
Simultaneous recording of LTCC current and Ca2+ transients were measured in EPI and 
ENDO ventricular cells according to modifications of previously described methods (27, 28, 31). 
All experiments were conducted at 34 °C. LTCC current was measured with an Axopatch 200B 
amplifier. Analog signal was filtered using a four-pole Bessel filter (bandwidth of 5 kHz) and 
digitized at a sampling rate of 10 kHz using a Digidata 1550 digitizer. The voltage clamp 
protocols, and data acquisition were controlled by WinWCP 4.05 software. Patch pipettes were 
made from filamented borosilicate glass. Resistance of electrodes was 2-4 MΩ. Seal resistances 
were 1–5 GΩ. Current–voltage (I-V) relationship was achieved by the application of 300 ms test 
pulses (-30 to +50 mV) in 10 mV steps from a holding potential of -40 mV. Intracellular Ca2+ 
recordings were obtained by loading the cells with 30 μM Fura-2-pentapotassium salt via the patch 
pipette for 5 min and excited at 360- and 380-nm wavelengths with dual LED light source, 
controlled by a spectrophotometry unit at 100 Hz. The fluorescence signal at 510 nm was 
collected through an adjustable diaphragm and a photomultiplier tube. WinWCP 4.05 software 
was used to sample signals at 10 kHz. All data were stored on a computer for subsequent analysis. 
After the subtraction of background signal, fluorescent signals were recorded as F360/F380 (ratio of 
the fluorescent intensity when excited at 360 nm (F360) to that when excited at 380 nm (F380) and 
expressed as a ratio unit (RU). Whole cell bath solution and pipette solution used are described in 
the supporting information.
Measurement of Na+/Ca2+ Exchange Current
NCX current was recorded according to modifications of previously described techniques (31) 
Experiments were conducted at 34 °C. Recording of NCX current was obtained with an Axopatch 
200B amplifier using a voltage ramp protocol. Cells were held at a holding potential of -40 mV. 
Voltage ramps were deployed at a steady rate of 0.1 V/s from +60 mV to −100 mV. Resistance of 
electrodes was 3-5 MΩ. Seal resistances were 1–5 GΩ. Oubain (100 μM), nifedipine (10 μM) and 
niflumic acid (30 μM) were used to block Na+-K+-ATPase, Ca2+, and Cl− currents, respectively. 
Nickel chloride solution (10 mM) was used to block NCX. The NCX current was measured as the 
current sensitive to nickel (Ni2+). NCX current was isolated by subtracting Ni2+-insensitive 
component from the total current (31). Whole cell bath solution and pipette solution used are 
described in supporting information.A
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Statistical Analysis
Results were represented as mean ± S.E.M. of ‘n’ observations. As appropriate, independent 
samples t-test or one-way ANOVA followed by Bonferroni corrected t-tests were used for 
statistical comparisons. P value < 0.05 was considered significant.
RESULTS
General Characteristics
Bodyweight and heart weight were significantly reduced (p<0.05) in STZ-pretreated diabetic 
rats. In comparison with their respective age-matched controls, heart weight/ bodyweight and non-
fasting blood glucose were greater in STZ-pretreated diabetic rats (Table 1).
Cell Capacitance
Cell capacitance was significantly lower in ENDO-STZ compared to ENDO-CON ventricular 
cells (p<0.05) (Figure 1). There was a small variation in cell capacitance between EPI-STZ and 
EPI-CON myocytes however, the variation was not significant (p>0.05).
L-type Ca2+ Current and Ca2+ Transient
Typical tracings of LTCC current and Ca2+ transients measured at  0 mV test potential are 
shown in Figure 2A. The mean current-voltage (I/V) relationship of LTCC current for ENDO-
STZ, ENDO-CON, EPI-STZ and EPI-CON ventricular cells are shown in Figure 2B and the 
currents generated at 0 mV test voltage are represented in Figure 2C. LTCC current amplitude 
were not significantly (p>0.05) different in ENDO-STZ and EPI-STZ compared to their respective 
controls at 0 mV (Figure 2C). Ca2+ transient fura-2 ratio-voltage relationship for ENDO-STZ, 
ENDO-CON, EPI-STZ and EPI-CON ventricular myocytes are represented in Figure 2D. Ca2+ 
transients generated at 0 mV are represented in Figure 2E. AMP of Ca2+ transients were 
significantly (p<0.05) larger in ENDO-STZ and EPI-STZ compared to their controls (Figure 2E). 
TPK LTCC current (Figure 2F) and TPK Ca2+ transient (Figure 2G) were not significantly 
(p>0.05) different in ENDO-STZ and EPI-STZ compared to their respective controls (p>0.05). 
THALF decay of LTCC current (Figure 2H) and THALF decay of the Ca2+ transient (Figure 2I) 
were not significantly (p<0.05) in ENDO-STZ and EPI-STZ compared to their respective controls.A
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Na+/Ca2+ Exchange Current
The current of NCX was recorded by applying a voltage ramp between +60 and -100 mV. The 
NCX current was calculated as the difference between current generated in presence of 10 µM 
nifedipine and current in presence of nifedipine and 10 mM Ni2+. Mean recordings of ramp current 
in ENDO-CON, ENDO-STZ, EPI-CON and EPI-STZ ventricular cells are represented in Figure 
3A. At +60 mV, the amplitude of NCX current was significantly (p<0.05) smaller in ENDO-STZ 
and in EPI-STZ compared to their respective controls (p<0.05) (Figure 3B). Similarly, at -100 
mV, the amplitude of NCX current was significantly (p<0.05) smaller in ENDO-STZ and EPI-
STZ compared to their respective controls (Figure 3C).
DISCUSSION
The findings of the study show that STZ-induced diabetes causes significant alteration in Ca2+ 
transients and NCX current in EPI and ENDO ventricular myocytes. To the best of our 
knowledge, this is the first study to investigate the regional effects of STZ-induced diabetes on 
LTCC current simultaneously measured with Ca2+ transients and NCX current in ventricular 
myocytes from STZ-induced diabetic rat.
Many changes during ECC may give rise to changes in the Ca2+ transient. In our experiments, 
the AMP and the kinetics of LTCC current were similar in rat ventricular cells from EPI compared 
to ENDO regions. The AMP of LTCC currents were not significantly different in ENDO-STZ and 
EPI-STZ ventricular cells compared to their controls. Although some studies have previously 
reported decreased AMP (12, 32), many studieshave reported no change in LTCC currents in 
ventricular cells from STZ-treated rat (4, 11, 33, 34).
Interestingly, the AMP of the Ca2+ transients were significantly larger in EPI-STZ and 
ENDO-STZ myocytes compared to their respective controls. However, no regional difference in 
Ca2+ transients was observed. Earlier studies have reported either reduced (4, 15, 35) or unaltered 
(16, 32, 36) Ca2+ transients in ventricular cells, isolated from STZ-induced diabetic animals. In 
comparison to other studies, in which Ca2+ transients were measured after 3-12 weeks of STZ 
treatment (16, 17, 32, 33, 37), our experiments were conducted in EPI and ENDO ventricular 
myocytes 5-6 months after STZ treatment. Thus, the variation in results may be partly related to 
the degree of progression of diabetes. Furthermore, the discrepancy between our data and other 
results, where decreased amplitude (38) or no change in amplitude (7) of the Ca2+ transients were A
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observed, may be down to the fact that different Ca2+ dyes were used for intracellular Ca2+ 
recordings. In our study, a low concentration of Fura-2-pentapotassium salt was dialysed into the 
cell via the patch pipette. However, other studies (7, 38) have used ester of Indo-1 (Indo-1/AM) to 
load the indicator. Although both are high affinity indicators that have been used for cytosolic 
Ca2+ measurements in many studies in cardiac myocytes and other cell types, variation in indicator 
and/or loading technique may account for different results. For example, the use of Indo-1 dye is 
sometimes associated with overloading of cytoplasm with Ca2+ indicator leading to increased 
buffering of Ca2+, slowing down the transients decay and reducing their amplitude. 
The observed rise in the amplitudes of Ca2+ transients is explained by changes in pathways of 
Ca2+ extrusion (e.g., NCX) which, along with SERCA, are responsible for decreasing cytosolic 
Ca2+. In our study, there was a significant decrease in NCX current in both EPI and ENDO 
ventricular cells, although no regional difference in the activity of NCX were observed. Earlier 
studies have also shown that the density of NCX current was reduced (7, 13, 39) and current 
inactivation was prolonged (13) in ventricular cells isolated from STZ-treated diabetic rat. These 
variations in the amplitude and kinetics of current were accompanied with decreased NCX mRNA 
(7) and reduced or unaltered  NCX protein in STZ-induced diabetic rat heart (8, 11, 40). It is 
possible that the decrease in Ca2+ extrusion rate via NCX leads to a net increase in intracellular 
Ca2+ (41), increase in SR Ca2+ load, and as a consequence, increased cytosolic Ca2+ transients (11, 
14, 17, 33, 42). Alternatively, the increase in the AMP of Ca2+ transients can be linked to 
ryanodine receptor (RyR) dysfunction. Abnormal function of RyR is associated with various 
diseases including cardiac hypertrophy and STZ-induced type 1 diabetes (43). It is known that the 
metabolic changes associated with diabetes stimulate the production of reactive oxygen species. 
As RyR structure is rich in free thiol groups, it is subject to oxidative stress, changing its tertiary 
structure and altering its sensitivity to Ca2+ (43, 44). In an earlier study in 7-week sedentary type 1 
diabetic rats, the frequency of Ca2+ spark was three times higher, and evoked release of Ca2+ was 
dys-synchronous with the diastolic release. Although the steady-state RyR protein was not altered, 
its response to Ca2+ was changed. The RyR also displayed about 1.5 times rise in phosphorylation 
at Ser 2808 and Ser 2814 residues (14).
In addition to the effects observed in diabetes, earlier studies have shown that hypertension-
induced cardiac hypertrophy causes an alteration in the AMP and the time course of systolic Ca2+ 
transients. Fowler et al. (2005) have shown that NCX activity is diminished while AMP of Ca2+ 
transient and SR Ca2+ content are increased in spontaneously hypertensive rats in comparison to A
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their respective controls (25). It was suggested that alteration in Ca2+ signaling during 
compensated hypertrophy is attributed to the reduction in ventricular myocyte NCX activity. As a 
result, SR Ca2+ content increases and thus, AMP of Ca2+ transient amplitude, serving to maintain 
the force of contraction against the elevated afterload (25, 45). This observation is consistent with 
the increased SR Ca2+ content of spontaneously hypertensive rat ventricular cells reported 
previously (46). Similarly, an increase in SR Ca2+ content,  SR Ca2+ release, and AMP of Ca2+ 
transients were also described in a canine model of compensated hypertrophy that was induced by 
chronic AV block (47). 
Earlier studies have also reported that abnormal intracellular Ca2+ transport is caused by the 
change in expression of proteins that modulate intracellular Ca2+. For example, Teshima et al. 
(2000) have shown that expression of SERCA and RyR mRNA were significantly altered in the 
heart, 3 and 12 weeks post STZ injection, respectively (23). Hattori et al. (2000) have shown that 
the reduction in cardiac NCX activity is due to the reduction in NCX mRNA and protein 6 weeks 
after the induction of diabetes with STZ  (7). Changes in the expression of mRNA that encodes 
different proteins in cardiac muscle have also been previously reported in data from our 
laboratory (48).
Transmural gradients in myocyte Ca2+ handling proteins exists across the ventricular wall. 
For example, it has been shown that Ca2+ handling proteins such as SERCA, RyR and NCX are 
more abundant in the EPI cells than ENDO cells in various species (49-51). Results of our study 
indicated that the amplitude of NCX current is larger in EPI-CON compared to END-CON. 
Supporting this finding, Xiong et al. (2005) reported that NCX current, protein and mRNA were 
greater in EPI than ENDO or MID cells (51). Wang et al. (2010) also reported transmural gradient 
in NCX with the capacity for Ca2+ extrusion by NCX being ENDO < MID < EPI (20). The spatial 
electrical heterogeneity of ion channels and proteins has a profound effect not only on normal 
cardiac electrophysiology and contractility, but also on the genesis of cardiac arrhythmias in 
diseased hearts. For example, the loss of this non-uniformity, has been previously reported to be 
a sensitive index to discriminate physiological from pathological left ventricular remodelling (21). 
The diminished NCX function in diabetic myocytes shown in this study suggest that NCX 
function may play an important role when Ca2+ rises to pathological levels, such as in diabetic 
cardiomyopathy. Furthermore, the disruption of the transmural NCX gradient in diabetic heart 
highlights a potential substrate for the production of lethal arrhythmias leading to heart failure in 
diabetic patient.A
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In conclusion, the present study suggests that STZ-induced diabetes causes a significant rise 
in Ca2+ transient amplitudes, 5-6 weeks after induction of diabetes with a single intraperitoneal 
injection of STZ. This change probably stems partly from the dysfunction of NCX. Additional 
studies would be needed to further our understanding of how diabetes alters Ca2+ handling in 
different regions of the heart. This will contribute to the development of new and regionally 
targeted treatments for diabetic cardiomyopathy.
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Table 1. General characteristics of streptozotocin-induced diabetic and age-matched control rats.
Data are mean ± SEM, n=15-17 rats; ** = p<0.05 for diabetic compared to control.
Figure 1. Mean cell capacitance in ENDO-CON, ENDO-STZ, EPI-CON and EPI-STZ myocytes.  
Data are mean ± SEM, n=13-17 cells from 10-14 hearts.
Figure 2. L-type Ca2+ channel (LTCC) current and Ca2+ transient in ENDO-CON, ENDO-
STZ, EPI-CON and EPI-STZ myocytes: (a) Typical recordings of LTCC current and Ca2+ 
transient at a test potential of 0 mV, (b) Mean recordings of LTCC current at test voltages in 
the range -30 to +50 mV, (c) Mean LTCC current at a test voltage of 0 mV, (d) Mean 
recordings of amplitude (AMP) of Ca2+ transients at test voltages in the range -30 to +50 mV, 
(e) Mean AMP of Ca2+ transients at a test potential of 0 mV, (f) TPK of LTCC current at test 
potentials in the range -30 to +50 mV, (g) TPK of Ca2+ transients at test potentials in the range 
-30 to + 50 mM, (h) Time to half  (THALF) decay of LTCC current at test potentials in the 
range -30 to +50 mV, (i) THALF of Ca2+ transients at test potentials in the range -30 to +50 
mV. Data are mean ± SEM, n=13-16 cells from 12-14 hearts; * = p<0.05.
Figure 3. Na+/Ca2+ exchange current in ENDO-CON, ENDO-STZ, EPI-CON and EPI-STZ 
myocytes: (a) Mean recordings of Na+/Ca2+ exchange current in (range:-100 to +60 mV), (b) 
Mean peak currents of Na+/Ca2+ exchange current at +60 mV, (c) Mean peak currents of 
Na+/Ca2+ exchange current at -100 mV. Data are mean ± SEM, n=14-17 cells from 9-11 
hearts. * = p<0.05. NCX: Na+/Ca2+ exchanger. 
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Table 1. General characteristics of streptozotocin-induced diabetic and age-matched control 
rats. 
 Control Streptozotocin 
Bodyweight (g) 417.3±9.9 274.2±8.6** 
Heart Weight (g) 1.45±0.03 1.28±0.03** 
Heart weight / Body weight (mg/g) 3.50±0.07 4.68±0.10** 
Non-fasting blood glucose (mg/dl) 83.3±1.31 483.9±20.2** 
Data are mean ± SEM, n=15-17 rats; ** = p<0.05 for diabetic compared to control.  
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